| Survivors | Non-survivors | P |
---|---|---|---|
n = 39 | n = 58 | ||
Blood flow (ml/min) | 180 ± 0 | 180 ± 0 | 1.00 |
Substitution flow (ml/h) | 2403 ± 16 | 2397 ± 59 | 0.54 |
Prescribed dose (ml/kg//h) | 24 ± 4 | 26 ± 6 | 0.13 |
Filter life (h) | 38 ± 24 | 23 ± 20 | 0.004 |
Reasons for termination (%) | Â | Â | 0.05 |
   Clotting | 41 | 47 | |
   Transfer to OR/radiology | 13 | 4 | |
   Renal function recovery | 24 | 9 | |
   Death of patient | 0 | 14 | |
   Elective change | 15 | 10 | |
   Citrate toxicity | 1 | 7 | |
   Miscellaneous | 6 | 13 | |
Citrate accumulation | 1 | 8 | 0.04 |
Changes in calcium infusion pump rate, | |||
day 1 | 2.2 ± 1.3 | 2.2 ± 1.5 | 0.99 |
day 2 | 1.6 ± 1.6 | 2.0 ± 2.0 | 0.37 |
day 3 | 1.5 ± 1.4 | 1.6 ± 1.2 | 0.70 |
day 5 | 1.6 ± 1.3 | 1.2 ± 1.1 | 0.99 |
day 7 | 1.9 ± 1.5 | 1.1 ± 1.1 | 0.18 |
Duration of CVVH (h) | 219 ± 237 | 223 ± 507 | 0.96 |